1
A Bioavailability Crossover Study of Two Formulations of Lamotrigine Extended Release Tablets in Healthy Subjects
Condition(s):HealthyLast Updated:May 1, 2020Completed
Lamotrigine Extended Release: 15 Clinical Trials, Page 1 of 2
Hide Studies Not Open or Pending
2
Lamotrigine Extended-Release Tablets 50 mg Under Fed Condition
Condition(s):HealthyLast Updated:June 28, 2013Completed
3
Bioequivalence Study of Lamotrigine Extended-Release Tablets 200mg Under Fed Condition
Condition(s):HealthyLast Updated:June 27, 2013Completed
4
Bioequivalence Study of Lamotrigine Extended-Release Tablets 50 mg Under Fasting Condition
Condition(s):HealthyLast Updated:June 28, 2013Completed
5
Bioequivalence Study of Lamotrigine Extended-Release Tablets 200mg Under Fasting Condition
Condition(s):HealthyLast Updated:June 27, 2013Completed
6
Lamotrigine Extended-Release In Elderly Patients With Epilepsy
Condition(s):EpilepsyLast Updated:January 18, 2017Completed
7
Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa
Condition(s):EpilepsyLast Updated:September 23, 2016Completed
8
Bioequivalence and Food Effect of 250mg of Lamotrigine XR
Condition(s):EpilepsyLast Updated:September 11, 2017Completed
9
Lamotrigine for Ketamine Dependence Trial
Condition(s):AddictionLast Updated:February 1, 2018Completed
10
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
Condition(s):Epilepsy; Epilepsy, PartialLast Updated:December 5, 2016Completed